Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department.

[1]  K. Lewandrowski,et al.  Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. , 2005, American journal of clinical pathology.

[2]  L. McCaig,et al.  National Hospital Ambulatory Medical Care Survey: 2000 Emergency Department Summary , 2002 .

[3]  J. Capeau,et al.  1002-83 Prognostic indications of a novel biological marker of cardiac ischemia in patients presenting with chest pain in an emergency setting , 2004 .

[4]  P O Collinson,et al.  Role of “Ischemia Modified Albumin”, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes , 2004, Emergency Medicine Journal.

[5]  P. Collinson,et al.  Ischemia Modified Albumin Is a Sensitive Marker of Myocardial Ischemia After Percutaneous Coronary Intervention , 2003, Circulation.

[6]  D. Morris,et al.  Ischemia modified albumin: A new biomarker of myocardial ischemia for early diagnosis of acute coronary syndromes , 2003 .

[7]  Carl J Pepine,et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients , 2002, Journal of the American College of Cardiology.

[8]  J. Ziffer,et al.  American society of nuclear cardiology position statement on radionuclide imaging in patients with suspected acute ischemic syndromes in the emergency department or chest pain center , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[9]  S. Campbell,et al.  A prospective, observational study of a chest pain observation unit in a British hospital , 2002, Emergency medicine journal : EMJ.

[10]  F. Hetzel,et al.  Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. , 2001, American heart journal.

[11]  Wendy R. Sanhai,et al.  Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. , 2001, Clinical chemistry.

[12]  G. Abreo,et al.  Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: angiographic correlates and long-term clinical outcomes. , 2000, Journal of the American College of Cardiology.

[13]  Robert Woolard,et al.  Missed Diagnoses of Acute Cardiac Ischemia in the Emergency Department , 2000 .

[14]  R. Califf,et al.  Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit. , 2000, The American journal of cardiology.

[15]  W. Peacock,et al.  Prediction of short- and long-term outcomes by troponin t levels in low-risk patients evaluated for acute coronary syndromes. , 2000, Annals of emergency medicine.

[16]  F. Fesmire,et al.  Usefulness of automated serial 12-lead ECG monitoring during the initial emergency department evaluation of patients with chest pain. , 1998, Annals of emergency medicine.

[17]  C. Heeschen,et al.  Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. , 1997, The New England journal of medicine.

[18]  Cindy Farquhar,et al.  3 The Cochrane Library , 1996 .

[19]  F. Harrell,et al.  Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia , 1996 .

[20]  D Wybenga,et al.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. , 1996, The New England journal of medicine.

[21]  J. Muhlestein,et al.  An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). , 1996, Journal of the American College of Cardiology.

[22]  B. Hesse,et al.  The diagnoses of patients admitted with acute chest pain but without myocardial infarction. , 1996, European heart journal.

[23]  L. Wallentin,et al.  Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemicals Markers of Acute Coronary Syndromes. , 1995, Coronary artery disease.

[24]  M. Sayre,et al.  A rapid diagnostic and treatment center for patients with chest pain in the emergency department. , 1995, Annals of emergency medicine.

[25]  J. Mcmanus.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial: The TIMI IIIB Investigators Circulation 89:1545–1556 Apr 1994 , 1994 .

[26]  L. Wilkins.  Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia. , 1994, Circulation.

[27]  W. Gibler,et al.  Emergency Department CK‐MB: A Predictor of Ischemic Complications , 1994, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[28]  R B D'Agostino,et al.  Missed diagnoses of acute myocardial infarction in the emergency department: results from a multicenter study. , 1993, Annals of emergency medicine.

[29]  W. Gibler,et al.  Acute myocardial infarction in chest pain patients with nondiagnostic ECGs: serial CK-MB sampling in the emergency department. The Emergency Medicine Cardiac Research Group. , 1992, Annals of emergency medicine.

[30]  G W Rouan,et al.  Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. , 1987, The American journal of cardiology.